Erasca, Inc. ERAS 深 沪
交易中 05-19 10:32:26 美东时间
10.175
-0.095
-0.93%
华盛通- 最 高10.44
- 今 开10.37
- 成交量 53.38万股
- 最 低 10.07
- 昨 收 10.27
- 总市值 31.64亿
- 52周最高 24.28
- 市盈率 静 --
- 换手率 0.17%
- 52周最低 1.21
- 委 比 91.20%
- 总股本 3.11亿
- 历史最高 24.47
- 量 比 1.25
- 振 幅 3.60%
- 历史最低 1.01
- 每 手 1
- 风险率 5.83%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Mizuho Maintains Outperform on Erasca, Lowers Price Target to $26
Mizuho analyst Joseph Catanzaro maintains Erasca (NASDAQ:ERAS) with a Outperform and lowers the price target from $28 to $26.
05-12 21:01
Erasca Q1 EPS $(0.60) Misses $(0.22) Estimate
Erasca (NASDAQ:ERAS) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.22) by 172.73 percent. This is a 445.45 percent decrease over losses of $(0.11) per share from the
05-12 05:28
Erasca Announces Clinical Trial Collaboration And Supply Agreement With Merck To Evaluate ERAS-0015 In Combination With Keytruda
This agreement supports a clinical proof-of-concept study, AURORAS-1, evaluating the pan-RAS molecular glue ERAS-0015 in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, for the treatment of
05-11 19:03
美股周涨跌榜 | 净回报超2600%！资管公司潘兴广场上市三日累涨超58%；慧荣科技周涨超52%
累计净回报超2600%！资管公司潘兴广场上市三日累涨超58%；慧荣科技周涨超52%，Q1营收同比翻倍大超预期>>
05-04 18:33
CommVault, Kforce, AxoGen And Other Big Stocks Moving Higher On Tuesday
U.S. stocks mixed, Nasdaq down 200 points. CommVault shares up 9.9% after beating earnings estimates. Other gainers include Kforce, Omnicell, and AxoGen.
04-28 22:06
Why Is Cancer Drug Developer Erasca Stock Plunging On Tuesday?
Erasca reports early ERAS-0015 data showing tumor response while rejecting Revolution Medicines' patent and trade secret allegations.
04-28 21:19
Why Bed Bath & Beyond Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
Shares of Bed Bath & Beyond (BBBY) rose 23.4% in pre-market trading after beating revenue estimates. KIDZ, CLDI, DRCT, PFSA, KFRC, MLEC, SANM, SEI, DT are also up while VISN, ERAS, AREB, and YAAS are down.
04-28 17:11
美股夜盘 | 新美亚电子涨15.27%，SOLARIS ENERGY INFRASTRUCTUR涨15.18%
新美亚电子涨15.27%；SOLARIS ENERGY INFRASTRUCTUR涨15.18%；LendingClub涨11.06%
04-28 15:01
美股夜盘 | SOLARIS ENERGY INFRASTRUCTUR涨16.79%，新美亚电子涨15.91%
SOLARIS ENERGY INFRASTRUCTUR涨16.79%；新美亚电子涨15.91%；LendingClub涨14.49%
04-28 13:01
